ROLE OF SPLANCHNIC EICOSANOIDS DURING SHOCK
内脏类二十烷酸在休克期间的作用
基本信息
- 批准号:6107531
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:eicosanoid metabolism free radical oxygen gastrointestinal absorption /transport gastrointestinal circulation gastrointestinal infection gastrointestinal motility /pressure hemorrhagic shock laboratory rat morphine multiple organ failure nitric oxide oxidative stress physiologic stressor platelets reperfusion septic shock serotonin vasoconstriction
项目摘要
Multiple organ failure (MOF) is a serious, often fatal sequelae of
visceral ischemia, resuscitation after severe hemorrhage, sepsis, or
following traumatic injury. The overall long term goal of this proposal
is to elucidate the humoral factors that contribute to the regulation of
splanchnic blood flow during hemorrhage/reperfusion injury. The
endogenous humoral factors that contribute to splanchnic blood flow that
will be studied include vasoactive eicosanoids and nitric oxide (NO).
The exogenous humoral factors investigated include platelet derived
vasoconstrictors and oxygen-derived free radicals (ODFRs) formed during
hemorrhage/reperfusion injury. Our long term goal is to investigate the
specific mechanisms involved in the regulation of the enzymes responsible
for eicosanoid and nitric oxide synthesis and degradation during shock
states which will contribute to the development of treatment strategies
designed to maintain splanchnic blood flow and visceral function
following shock.
Acute hemorrhage followed by reperfusion will be used either as a primary
injury or as an initial injury followed by a second insult to examine the
following specific aims: 1) To determine the role of ODFRs on splanchnic
eicosanoid synthesis and NO synthesis following early hemorrhagic shock
and reperfusion; 2) to determine the role of ODFR on the regulation of
splanchnic blood flow following hemorrhagic shock and reperfusion; 3) To
determine the role of local platelet eicosanoid and serotonin release in
the splanchnic vascular bed following hemorrhagic shock and reperfusion;
4) To determine the role of a second trauma (endotoxin shock, hemorrhage)
on splanchnic eicosanoid and NO synthesis and splanchnic blood flow
following initial hemorrhagic shock.
This proposal will utilize several strategies to determine the role of
ODFRs on splanchnic eicosanoid and NO synthesis and splanchnic blood flow
during shock. The first strategy will examine the effects of
hemorrhage/reperfusion injury on splanchnic eicosanoid and nitric oxide
synthesis and release. These studies will determine the location and
molecular mechanisms involved with the regulation of the enzymes
responsible for splanchnic eicosanoid and nitric oxide synthesis during
hemorrhage/reperfusion injury. The second strategy is to examine the
effects of ODFRs on splanchnic blood flow following
hemorrhage/reperfusion injury. The third strategy is to examine the
contribution of platelets to splanchnic vasoconstriction during
hemorrhage/reperfusion by release of serotonin and thromboxane. The
fourth strategy is to determine the effect of a second trauma
(hemorrhage, endotoxin, morphine etc.) on the splanchnic eicosanoid and
nitric oxide synthesis and splanchnic blood flow following initial
hemorrhage.
多器官衰竭(MOF)是一种严重的,往往是致命的后遗症,
内脏缺血,严重出血后复苏,败血症,或
创伤性损伤后。 本提案的总体长期目标
是阐明体液因素,有助于调节
出血/再灌注损伤时内脏血流量。 的
内源性体液因子,有助于内脏血流量,
包括血管活性类花生酸和一氧化氮(NO)。
研究的外源性体液因子包括血小板衍生的
血管收缩剂和氧衍生自由基(ODFRs)形成的过程中,
出血/再灌注损伤。 我们的长期目标是调查
参与调节酶的特定机制
在休克期间类花生酸和一氧化氮的合成和降解
有助于制定治疗战略的国家
旨在维持内脏血流量和内脏功能
休克后。
急性出血后再灌注将被用作原发性
伤害或作为第一次伤害,然后是第二次侮辱,以检查
1)确定ODFRs对内脏器官的作用,
失血性休克早期类花生酸合成和NO合成
2)探讨ODFR对缺血再灌注损伤的调节作用。
失血性休克和再灌注后内脏血流量; 3)
确定局部血小板类花生酸和5-羟色胺释放在
失血性休克再灌注后内脏血管床;
4)确定二次创伤(内毒素休克、出血)的作用
对内脏类花生酸和NO合成及内脏血流量的影响
在最初的失血性休克之后
本提案将利用若干战略来确定以下方面的作用:
内脏类花生酸和NO合成与内脏血流量的ODFRs
在休克期间。 第一项战略将研究
失血/再灌注损伤对内脏类花生酸和一氧化氮影响
合成和释放。 这些研究将确定地点,
参与酶调节的分子机制
负责内脏类花生酸和一氧化氮的合成,
出血/再灌注损伤。 第二个策略是检查
ODFRs对内脏血流量的影响
出血/再灌注损伤。 第三个策略是检查
血小板对内脏血管收缩的作用
通过释放5-羟色胺和血栓素引起的出血/再灌注。 的
第四种策略是确定第二次创伤的影响
(出血、内毒素、吗啡等)内脏类花生酸,
一氧化氮合成和内脏血流量
出血
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STUART I MYERS其他文献
STUART I MYERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STUART I MYERS', 18)}}的其他基金
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6517993 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6594708 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6799078 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6661237 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6660453 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6941409 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6449709 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6941574 - 财政年份:2001
- 资助金额:
-- - 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
- 批准号:
6775528 - 财政年份:2001
- 资助金额:
-- - 项目类别:














{{item.name}}会员




